Indirapriya Darshini Avulakunta, MD - Medicare Pediatrics in Little Rock, AR

Indirapriya Darshini Avulakunta, MD is a medicare enrolled "Pediatrics - Neonatal-perinatal Medicine" physician in Little Rock, Arkansas. Her current practice location is 1 Childrens Way # 512-1, Little Rock, Arkansas. You can reach out to her office (for appointments etc.) via phone at (501) 364-5262.

Indirapriya Darshini Avulakunta is licensed to practice in Arkansas (license number E-15358) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1003369901.

Contact Information

Indirapriya Darshini Avulakunta, MD
1 Childrens Way # 512-1,
Little Rock, AR 72202-3500
(501) 364-5262
(501) 364-3418



Physician's Profile

Full NameIndirapriya Darshini Avulakunta
GenderFemale
SpecialityPediatrics - Neonatal-perinatal Medicine
Location1 Childrens Way # 512-1, Little Rock, Arkansas
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003369901
  • Provider Enumeration Date: 07/27/2016
  • Last Update Date: 08/05/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9830572874
  • Enrollment ID: I20220824000121

Medical Identifiers

Medical identifiers for Indirapriya Darshini Avulakunta such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003369901NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics E-15358 (Arkansas)Secondary
2080N0001XPediatrics - Neonatal-perinatal Medicine E-15358 (Arkansas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Indirapriya Darshini Avulakunta allows following entities to bill medicare on her behalf.
Entity NameUniversity Of Arkansas For Medical Sciences
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588654016
PECOS PAC ID: 4082528955
Enrollment ID: O20031219000706

News Archive

Alzheimer's mechanism suggests combination therapy needed

Researchers at the University of Illinois at Chicago College of Medicine have discovered a mode of action for mysterious but diagnostic protein snarls found in the brains of Alzheimer's patients that suggests a one-two punch of therapy may be needed to combat the neurodegenerative disease.

Study challenges NICE guidelines that recommend SSRIs be prescribed only in conjunction with psychological therapies

Should adolescents with depression be prescribed antidepressants, and if so, should they be given only with a psychological therapy, as advocated by the National Institute for Health and Clinical Excellence (NICE)"

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago.

WHO announces new guidelines for production, regulation and control of snake antivenoms

With snake bites killing at least 100 000 people a year and countries facing a shortage of appropriate antivenoms, access to and information about available antivenoms is increasingly important. The World Health Organization (WHO) is publishing new guidelines for the production, regulation and control of snake antivenoms and a website with details on where the venomous snakes are located, what they look like, which antivenoms are appropriate, and where they can be obtained.

Cambridge Labs announces Spanish approval of Tetrabenazine

Cambridge Laboratories Limited has announced that its flagship product Tetrabenazine, (known as NITOMAN in Germany and other key European territories and XENAZINE in the UK, U.S. and other markets) has received marketing approval in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios.

Read more Medical News

› Verified 8 days ago

Entity NameUniversity Of Arkansas For Medical Sciences
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346230968
PECOS PAC ID: 4082528955
Enrollment ID: O20040115000431

News Archive

Alzheimer's mechanism suggests combination therapy needed

Researchers at the University of Illinois at Chicago College of Medicine have discovered a mode of action for mysterious but diagnostic protein snarls found in the brains of Alzheimer's patients that suggests a one-two punch of therapy may be needed to combat the neurodegenerative disease.

Study challenges NICE guidelines that recommend SSRIs be prescribed only in conjunction with psychological therapies

Should adolescents with depression be prescribed antidepressants, and if so, should they be given only with a psychological therapy, as advocated by the National Institute for Health and Clinical Excellence (NICE)"

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago.

WHO announces new guidelines for production, regulation and control of snake antivenoms

With snake bites killing at least 100 000 people a year and countries facing a shortage of appropriate antivenoms, access to and information about available antivenoms is increasingly important. The World Health Organization (WHO) is publishing new guidelines for the production, regulation and control of snake antivenoms and a website with details on where the venomous snakes are located, what they look like, which antivenoms are appropriate, and where they can be obtained.

Cambridge Labs announces Spanish approval of Tetrabenazine

Cambridge Laboratories Limited has announced that its flagship product Tetrabenazine, (known as NITOMAN in Germany and other key European territories and XENAZINE in the UK, U.S. and other markets) has received marketing approval in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios.

Read more Medical News

› Verified 8 days ago

Entity NameArkansas Childrens Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598773079
PECOS PAC ID: 2769477744
Enrollment ID: O20040419000796

News Archive

Alzheimer's mechanism suggests combination therapy needed

Researchers at the University of Illinois at Chicago College of Medicine have discovered a mode of action for mysterious but diagnostic protein snarls found in the brains of Alzheimer's patients that suggests a one-two punch of therapy may be needed to combat the neurodegenerative disease.

Study challenges NICE guidelines that recommend SSRIs be prescribed only in conjunction with psychological therapies

Should adolescents with depression be prescribed antidepressants, and if so, should they be given only with a psychological therapy, as advocated by the National Institute for Health and Clinical Excellence (NICE)"

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago.

WHO announces new guidelines for production, regulation and control of snake antivenoms

With snake bites killing at least 100 000 people a year and countries facing a shortage of appropriate antivenoms, access to and information about available antivenoms is increasingly important. The World Health Organization (WHO) is publishing new guidelines for the production, regulation and control of snake antivenoms and a website with details on where the venomous snakes are located, what they look like, which antivenoms are appropriate, and where they can be obtained.

Cambridge Labs announces Spanish approval of Tetrabenazine

Cambridge Laboratories Limited has announced that its flagship product Tetrabenazine, (known as NITOMAN in Germany and other key European territories and XENAZINE in the UK, U.S. and other markets) has received marketing approval in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Indirapriya Darshini Avulakunta is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Indirapriya Darshini Avulakunta, MD
1 Childrens Way # 653,
Little Rock, AR 72202-3500

Ph: (501) 686-8000
Indirapriya Darshini Avulakunta, MD
1 Childrens Way # 512-1,
Little Rock, AR 72202-3500

Ph: (501) 364-5262

News Archive

Alzheimer's mechanism suggests combination therapy needed

Researchers at the University of Illinois at Chicago College of Medicine have discovered a mode of action for mysterious but diagnostic protein snarls found in the brains of Alzheimer's patients that suggests a one-two punch of therapy may be needed to combat the neurodegenerative disease.

Study challenges NICE guidelines that recommend SSRIs be prescribed only in conjunction with psychological therapies

Should adolescents with depression be prescribed antidepressants, and if so, should they be given only with a psychological therapy, as advocated by the National Institute for Health and Clinical Excellence (NICE)"

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago.

WHO announces new guidelines for production, regulation and control of snake antivenoms

With snake bites killing at least 100 000 people a year and countries facing a shortage of appropriate antivenoms, access to and information about available antivenoms is increasingly important. The World Health Organization (WHO) is publishing new guidelines for the production, regulation and control of snake antivenoms and a website with details on where the venomous snakes are located, what they look like, which antivenoms are appropriate, and where they can be obtained.

Cambridge Labs announces Spanish approval of Tetrabenazine

Cambridge Laboratories Limited has announced that its flagship product Tetrabenazine, (known as NITOMAN in Germany and other key European territories and XENAZINE in the UK, U.S. and other markets) has received marketing approval in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios.

Read more News

› Verified 8 days ago


Pediatrics Doctors in Little Rock, AR

Amber Michele Morse, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 1 Childrens Way # 512-16, Little Rock, AR 72202
Phone: 501-364-1050    Fax: 501-364-6931
Dustin Edward Williford, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 1 Childrens Way # 512-8, Little Rock, AR 72202
Phone: 501-364-1100    Fax: 501-364-2963
Kristyn N Jeffries, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 1 Childrens Way # 512-1, Little Rock, AR 72202
Phone: 501-364-5262    Fax: 501-364-3418
Mohy Morris, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 1 Childrens Way # 512-17, Little Rock, AR 72202
Phone: 501-364-1100    Fax: 501-364-3930
Ashley Wilcox Halpain, M.D.
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 904 Autumn Rd Ste 100, Little Rock, AR 72211
Phone: 501-224-5437    
Carl Preston Mccormack, MD
Pediatrics
Medicare: Accepting Medicare Assignments
Practice Location: 1001 N University Ave Ste 150, Little Rock, AR 72207
Phone: 501-361-3249    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.